^
BIOMARKER:

MAP2K1 mutation

i
Other names: MAP2K1, MAPKK1, MEK1, PRKMK1, Mitogen-activated protein kinase kinase 1
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
Related biomarkers:
MAP2K1 mutation
Non Small Cell Lung Cancer
lorlatinib
Resistant
:
C3
MAP2K1 mutation
Melanoma
CTLA4 inhibitor
Sensitive
:
C3
MAP2K1 mutation
Biliary Tract Cancer
trametinib
Sensitive
:
C3
MAP2K1 mutation
Lung Non-Squamous Non-Small Cell Cancer
binimetinib
Sensitive
:
C3
MAP2K1 mutation
Pancreatic Ductal Adenocarcinoma
avelumab + binimetinib
Sensitive
:
C3
MAP2K1 mutation
Ovarian Cancer
selumetinib
Sensitive
:
C4
MAP2K1 mutation
Melanoma
dabrafenib
Resistant
:
D
MAP2K1 mutation
Melanoma
trametinib
Resistant
:
D